About the Product

Description


Torslide S 5 - 50 Tablet containing Torsemide and Spironolactone is a potent diuretic combination formulated for effective cardiovascular and renal care. It helps in reducing fluid overload, controlling edema, and managing hypertension, making it highly beneficial in conditions like congestive heart failure, liver cirrhosis, and kidney disorders.

Torsemide is a loop diuretic that works by increasing urine output, thereby eliminating excess salt and water from the body. Spironolactone, a potassium-sparing diuretic, helps in retaining potassium while promoting fluid removal, preventing electrolyte imbalance and enhancing the overall safety profile of the therapy.

This dual-action combination ensures efficient fluid management while maintaining electrolyte stability, leading to improved patient outcomes and better tolerance. It is widely prescribed for long-term management of edema and hypertension, offering reliable and consistent therapeutic benefits.

With rising cases of cardiovascular and renal disorders, this formulation holds strong demand in chronic therapy segments. Its excellent prescription adaptability, steady market movement, and high patient compliance make it a valuable addition for expanding presence in the cardio-diuretic segment and achieving sustained business growth.

Common side effects include dehydration, electrolyte imbalances (low potassium, sodium), dizziness, low blood pressure, headache, and muscle cramps. Serious but rare effects may include hearing disturbances, kidney dysfunction, or severe hypotension.

Torslide Injection is indicated for the treatment of acute pulmonary edema, congestive heart failure, severe hypertension, and fluid retention caused by kidney or liver disease in patients needing immediate diuresis.

This medication should be administered only under the supervision of a healthcare professional. Regular monitoring of blood pressure, electrolyte levels, and kidney function is required to prevent complications. Avoid use in patients with severe dehydration or kidney failure without medical advice

Store at room temperature (15-30°C), away from light and moisture. Keep it in a secure place and do not freeze. Use only if the solution is clear and free from particles.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

1. What are the business opportunities for Torsemide 5mg + Spironolactone 50mg Tablet in the PCD pharma franchise market?

Torsemide 5mg + Spironolactone 50mg Tablet is a widely prescribed combination in the cardiology, nephrology, and internal medicine segment. The growing prevalence of cardiovascular disorders, fluid retention conditions, and related renal complications has increased the demand for combination diuretic therapies. This makes the product a profitable opportunity for pharma franchise partners, distributors, stockists, and wholesalers seeking to expand their cardiac and renal care portfolio.

2. Why should medical distributors include Torsemide 5mg + Spironolactone 50mg Tablet in their product range?

Medical distributors and pharma franchise companies can benefit from the consistent demand for combination diuretic therapies prescribed under medical supervision. Torsemide 5mg is a loop diuretic that helps remove excess fluid from the body by increasing urine output Spironolactone 50mg is a potassium-sparing diuretic that helps manage fluid retention while supporting potassium balance Commonly prescribed for patients requiring combination diuretic therapy under medical guidance Frequently recommended by cardiologists, nephrologists, and physicians Helps support comprehensive fluid management strategies in cardiovascular and renal care Widely utilized in hospitals, specialty clinics, and outpatient healthcare settings This combination strengthens a comprehensive cardiology, nephrology, and internal medicine portfolio.

3. Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for Torsemide 5mg + Spironolactone 50mg Tablet?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Torsemide 5mg + Spironolactone 50mg Tablet. Franchise partners receive monopoly rights, promotional support, attractive packaging, competitive pricing, and reliable supply chain assistance to help grow their pharmaceutical business successfully.

4. What benefits do wholesalers get by partnering for this product?

Wholesalers, distributors, and medical agencies can benefit from: Strong prescription demand in the cardiology and nephrology segments Regular repeat orders due to ongoing treatment requirements Wide acceptance among cardiologists, nephrologists, and general physicians Attractive profit margins and business growth opportunities Reliable product availability and efficient logistics support Enhanced cardiac and renal care product portfolio

5. How can I become a distributor or franchise partner for this product?

Interested distributors, wholesalers, stockists, and pharma professionals can partner with Cafoli LifeCare Pvt Ltd to market Torsemide 5mg + Spironolactone 50mg Tablet across India. With exclusive monopoly-based franchise opportunities, comprehensive promotional support, quality-assured formulations, attractive business margins, competitive pricing, and dependable logistics assistance, Cafoli LifeCare Pvt Ltd helps partners establish and expand a successful pharmaceutical business.